APOC1 antibody (Biotin)

Catalog No. ABIN7449293

Product Details anti-APOC1 Antibody (Biotin)

Target: APOC1 (Apolipoprotein C-I (APOC1))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This APOC1 antibody is conjugated to Biotin

Application: Western Blotting (WB), ELISA

Purpose: Goat anti-Human Apo CI [B07] Antibody Biotin Conjugated

Immunogen: Human Apolipoprotein CI

Clone: B07

Isotype: IgG

Application Details

Application Notes:

WB: 1:1,000 - 1:20,000

ELISA: 1:1,000 - 1:20,000

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Expiry Date: 12 months

Target Details for APOC1

Target: APOC1 (Apolipoprotein C-I (APOC1))

Alternative Name: ApoCI (APOC1 Products)

Synonyms: Apo-CIB antibody, ApoC-IB antibody, ALPCI antibody, LRRG04 antibody, APOC1 antibody, apoc1 antibody, apolipoprotein C1 antibody, apolipoprotein C-I antibody, Apolipoprotein C-I antibody, APOC1 antibody, Apoc1 antibody, apoc1 antibody

Background: Background: ApoCI contains 57 amino acid residues and the m.w. is 6.6 kDa (Jackson et al., 1974). ApoCI has been found to activate LCAT (Liu and Subbaiah 1993). Apo CI is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. Apo CI is also an inhibitor of the plasma cholesteryl ester transfer protein and of fatty acid uptake into tissues (Shachter, 2001). This inhibition role can potentially regulate several lipase enzymes. (Poensgen, 1990, Conde-Knape et al., 2002, Berbee et al., 2005)

Gene ID: 341

NCBI Accession: NP_001636

UniProt: P02654

Pathways: Apoptosis